Form 483

TEIKOKU SEIYAKU CO.,LTD. Form 483, 2014-03-14

FDA issued a Form 483 to TEIKOKU SEIYAKU CO.,LTD. on 2014-03-14 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

TEIKOKU SEIYAKU CO.,LTD. · Higashikagawa, Japan · Issued March 14, 2014

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

14 Mar 2014
21 CFR 211.84(b)

Representative Samples

Cited by Vlada Matusovsky, Sina Shojaee

14 Mar 2014
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Vlada Matusovsky, Sina Shojaee

14 Mar 2014
21 CFR 211.113(a)

Procedures for non-sterile drug products

Cited by Vlada Matusovsky, Sina Shojaee

14 Mar 2014
21 CFR 211.180(b)

Record maintenance 1 year (except exempt OTC)

Cited by Vlada Matusovsky, Sina Shojaee

14 Mar 2014
21 CFR 211.194(a)(2)

Suitability of testing methods verified

Cited by Vlada Matusovsky, Sina Shojaee

Inspected site

TSTEIKOKU SEIYAKU CO.,LTD.Higashikagawa, Japan

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.113(a)Cited across public-safe Form 483 observations1x
21 CFR 211.180(b)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.198(b)(3)Cited across public-safe Form 483 observations1x
21 CFR 211.84(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 6 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere